Anebulo Pharmaceuticals Statistics
Total Valuation
ANEB has a market cap or net worth of $59.64 million. The enterprise value is $54.50 million.
| Market Cap | 59.64M |
| Enterprise Value | 54.50M |
Important Dates
The last earnings date was Wednesday, May 15, 2024.
| Earnings Date | May 15, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ANEB has 25.93 million shares outstanding. The number of shares has increased by 1.17% in one year.
| Shares Outstanding | 25.93M |
| Shares Change (YoY) | +1.17% |
| Shares Change (QoQ) | +0.56% |
| Owned by Insiders (%) | 65.38% |
| Owned by Institutions (%) | 28.17% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 11.96 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.32, with zero debt.
| Current Ratio | 5.32 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -101.12 |
Financial Efficiency
Return on equity (ROE) is -123.00% and return on invested capital (ROIC) is -189.81%.
| Return on Equity (ROE) | -123.00% |
| Return on Assets (ROA) | -109.30% |
| Return on Capital (ROIC) | -189.81% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$4.67M |
| Employee Count | 2 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -0.86% in the last 52 weeks. The beta is -0.99, so ANEB's price volatility has been lower than the market average.
| Beta (1Y) | -0.99 |
| 52-Week Price Change | -0.86% |
| 50-Day Moving Average | 2.72 |
| 200-Day Moving Average | 2.63 |
| Relative Strength Index (RSI) | 35.80 |
| Average Volume (30 Days) | 6,020 |
Short Selling Information
The latest short interest is 17,857, so 0.07% of the outstanding shares have been sold short.
| Short Interest | 17,857 |
| Short Previous Month | 20,117 |
| Short % of Shares Out | 0.07% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 3.22 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -9.46M |
| Pretax Income | -9.35M |
| Net Income | -9.35M |
| EBITDA | -9.26M |
| EBIT | -9.26M |
| Earnings Per Share (EPS) | -$0.37 |
Balance Sheet
The company has $5.15 million in cash and no debt, giving a net cash position of $5.15 million or $0.20 per share.
| Cash & Cash Equivalents | 5.15M |
| Total Debt | n/a |
| Net Cash | 5.15M |
| Net Cash Per Share | $0.20 |
| Equity / Book Value | 4.99M |
| Book Value Per Share | 0.19 |
| Working Capital | 4.36M |
Cash Flow
| Operating Cash Flow | -8.89M |
| Capital Expenditures | n/a |
| Free Cash Flow | -8.89M |
| FCF Per Share | -$0.34 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ANEB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.17% |
| Shareholder Yield | -1.17% |
| Earnings Yield | -15.67% |
| FCF Yield | -14.90% |
Analyst Forecast
The average price target for ANEB is $6.67, which is 190.00% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $6.67 |
| Price Target Difference | 190.00% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |